Cargando…

Anemia in Children with Down Syndrome

Background. Iron deficiency anemia impacts on cognitive development. The objective of this study was to determine the prevalence of anemia and iron deficiency in children with Down syndrome and identify risk factors for anemia. Methods. We conducted a prolective cross-sectional study of children att...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tenenbaum, Ariel, Malkiel, Sarah, Wexler, Isaiah D., Levy-Khademi, Floris, Revel-Vilk, Shoshana, Stepensky, Polina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173951/ https://www.ncbi.nlm.nih.gov/pubmed/21941570 http://dx.doi.org/10.1155/2011/813541

Ejemplares similares

Hospitalization of Children with Down Syndrome
por: Tenenbaum, Ariel, et al.
Publicado: (2014)

Fertility preservation in young cancer patients
por: Revel, Ariel, et al.
Publicado: (2010)

Patient blood management programs: how to spread the word?
por: Revel-Vilk, Shoshana, et al.
Publicado: (2018)

Elevating hope among children with Attention deficit and hyperactivity disorder through virtual reality
por: Shiri, Shimon, et al.
Publicado: (2014)

Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
por: Revel-Vilk, Shoshana, et al.
Publicado: (2020)

Official communication of the SSC: Recommendations for future research in catheter‐related arterial thrombosis in children
por: Albisetti, Manuela, et al.
Publicado: (2019)

Fetal alcohol spectrum disorder among pre-adopted and foster children
por: Tenenbaum, Ariel, et al.
Publicado: (2020)

Simultaneous Bilateral Femoral Osteonecrosis in Gaucher Disease
por: Cohen, Daniel, et al.
Publicado: (2023)

Anesthetic Approaches and Perioperative Complications of Total Hip Arthroplasty in Gaucher Disease: A Control-Matched Retrospective-Cohort Study
por: Grass, Ariel, et al.
Publicado: (2023)

Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy
por: Istaiti, Majdolen, et al.
Publicado: (2022)

High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction Therapy
por: Istaiti, Majdolen, et al.
Publicado: (2023)

The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy
por: Zimran, Ari, et al.
Publicado: (2023)

Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease
por: Dinur, Tama, et al.
Publicado: (2020)

Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population
por: Steinberg-Shemer, Orna, et al.
Publicado: (2020)

Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease
por: Azoulay, David, et al.
Publicado: (2022)

Alopecia Areata and Down Syndrome: A True Association or a Coincidence
por: Ramot, Yuval, et al.
Publicado: (2013)

A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative
por: Collin-Histed, Tanya, et al.
Publicado: (2023)

Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease
por: Hurvitz, Noa, et al.
Publicado: (2019)

Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations
por: Dinur, Tama, et al.
Publicado: (2021)

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022)

Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
por: Weill, Yishay, et al.
Publicado: (2020)

Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease
por: Dinur, Tama, et al.
Publicado: (2019)

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease
por: Dinur, Tama, et al.
Publicado: (2023)

Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness
por: Goldenberg, Neil A., et al.
Publicado: (2020)

Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes
por: Fink, Orly, et al.
Publicado: (2022)

Pediatric overweight and obesity increased in Israel during the COVID-19 period
por: Rose, Adam, et al.
Publicado: (2023)

Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa
por: Zimran, Ari, et al.
Publicado: (2018)

Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
por: Dinur, Tama, et al.
Publicado: (2022)

Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
por: Hughes, Derralynn A., et al.
Publicado: (2022)

Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”
por: Hughes, Derralynn A., et al.
Publicado: (2023)

P1633: LOW SERUM BDNF LEVELS ARE ASSOCIATED WITH LOWER PLATELETS’ CD62P REACTIVITY AND INCREASED BLEEDING TENDENCY IN PATIENTS WITH GAUCHER DISEASE
por: Azoulay, D., et al.
Publicado: (2022)

Blood cytology in children with down syndrome
por: García de la Puente, Silvestre, et al.
Publicado: (2022)

Healthy Growth in Children with Down Syndrome
por: Van Gameren-Oosterom, Helma B. M., et al.
Publicado: (2012)

Heart Transplantation in Children With Down Syndrome
por: Godown, Justin, et al.
Publicado: (2022)

The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)

Oxidative Stress -a Phenotypic Hallmark of Fanconi Anemia and Down Syndrome: The Effect of Antioxidants
por: El-Bassyouni, HT, et al.
Publicado: (2015)

A Deep-Learning Approach to Spleen Volume Estimation in Patients with Gaucher Disease
por: Azuri, Ido, et al.
Publicado: (2023)

Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study
por: Revel-Vilk, Shoshana, et al.
Publicado: (2023)

Melatonin as an immunomodulator in children with Down syndrome
por: Huggard, Dean, et al.
Publicado: (2021)

Children with Down syndrome : a developmental perspective
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_o9866mddv2afc0qhqfcseti34s